Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Dreslinski

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The American Journal of Medicine|September 26, 1983
Identification of left ventricular hypertrophy: chest roentgenography, echocardiography, and electrocardiographyG R Dreslinski
Archives of Internal Medicine|November 1, 1985
Captopril in the treatment of the elderly hypertensive patientA C Jenkins, J R Knill, G R Dreslinski
Reviews of Infectious Diseases|November 1, 1985
Safety profile of aztreonam in clinical trialsT J Newman, G R Dreslinski, S S Tadros
Hypertension (Dallas, Tex. : 1979)|September 1, 1983
Long-term antihypertensive therapy with captoprilJ T Groel, S S Tadros, G R Dreslinski, et al.
The American Journal of Cardiology|July 1, 1982
Early hypertension and cardiac workG R Dreslinski, F H Messerli, F G Dunn, et al.
Chest|November 1, 1981
Patterns of left ventricular adaptation in borderline and mild essential hypertension. Echocardiographic findingsG R Dreslinski, F H Messerli, F G Dunn, et al.
Clinical Science (London, England : 1979)|December 1, 1980
Asymptomatic mild hyperuricaemia: an indicator of nephrosclerosis in essential hypertensionF H Messerli, E D Frohlich, G R Dreslinski, et al.
Annals of Internal Medicine|December 1, 1980
Serum uric acid in essential hypertension: an indicator of renal vascular involvementF H Messerli, E D Frohlich, G R Dreslinski, et al.
Clinical Pharmacology and Therapeutics|November 1, 1979
Effects of beta blockade with acebutolol on hypertension, hemodynamics, and fluid volumeG R Dreslinski, G G Aristimuno, F H Messerli, et al.
Clinical Pharmacology and Therapeutics|February 1, 1983
Hemodynamic effects of intravenous labetalol in essential hypertensionF G Dunn, W Oigman, F H Messerli, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The American Journal of Medicine|September 26, 1983
Identification of left ventricular hypertrophy: chest roentgenography, echocardiography, and electrocardiographyG R Dreslinski
Archives of Internal Medicine|November 1, 1985
Captopril in the treatment of the elderly hypertensive patientA C Jenkins, J R Knill, G R Dreslinski
Reviews of Infectious Diseases|November 1, 1985
Safety profile of aztreonam in clinical trialsT J Newman, G R Dreslinski, S S Tadros
Hypertension (Dallas, Tex. : 1979)|September 1, 1983
Long-term antihypertensive therapy with captoprilJ T Groel, S S Tadros, G R Dreslinski, et al.
The American Journal of Cardiology|July 1, 1982
Early hypertension and cardiac workG R Dreslinski, F H Messerli, F G Dunn, et al.
Chest|November 1, 1981
Patterns of left ventricular adaptation in borderline and mild essential hypertension. Echocardiographic findingsG R Dreslinski, F H Messerli, F G Dunn, et al.
Clinical Science (London, England : 1979)|December 1, 1980
Asymptomatic mild hyperuricaemia: an indicator of nephrosclerosis in essential hypertensionF H Messerli, E D Frohlich, G R Dreslinski, et al.
Annals of Internal Medicine|December 1, 1980
Serum uric acid in essential hypertension: an indicator of renal vascular involvementF H Messerli, E D Frohlich, G R Dreslinski, et al.
Clinical Pharmacology and Therapeutics|November 1, 1979
Effects of beta blockade with acebutolol on hypertension, hemodynamics, and fluid volumeG R Dreslinski, G G Aristimuno, F H Messerli, et al.
Clinical Pharmacology and Therapeutics|February 1, 1983
Hemodynamic effects of intravenous labetalol in essential hypertensionF G Dunn, W Oigman, F H Messerli, et al.
Pageof 3